Novartis Challenges USPTO Patent Extension Policy
Novartis AG has filed suit against the U.S. Patent and Trademark Office, claiming that the agency's interim method for recalculating patent term adjustments in light of Wyeth v. Kappos has effectively...To view the full article, register now.
Already a subscriber? Click here to view full article